Global EBER Probe Market Growth 2026-2032
Description
The global EBER Probe market size is predicted to grow from US$ 102 million in 2025 to US$ 167 million in 2032; it is expected to grow at a CAGR of 7.3% from 2026 to 2032.
EBER probes are nucleic acid probes used for in situ hybridization (ISH) to detect Epstein-Barr virus (EBV)-encoding small RNAs (EBER1/2). They are commonly used in FFPE tissue sections for nucleus staining/fluorescence localization, aiding in the determination of latent EBV infection and related tumor subtyping.
Upstream: Oligonucleotide/probe design and synthesis, labeling (DIG/biotin/fluorescence), enzymes and buffers, slides and mounting materials. Downstream: Hospital pathology departments and third-party testing, tumor/lymphoma and nasopharyngeal carcinoma diagnosis, transplant follow-up, and research institutions.
In 2025, the global unit price of EBER probes was $619, with sales of 169,000 units and a global annual production capacity of 180,000 units. The industry profit margin was 25-30%.
Global Market Trends:
Clinical demand for refined subtyping of EBV-related diseases is increasing. EBER-ISH, due to its ability to locate infected cells at the tissue level, will remain a key detection method; its penetration rate continues to increase in the management of lymphoma, nasopharyngeal carcinoma, and immunosuppression-related diseases.
Platforms are accelerating automation and standardization: More laboratories are adopting ready-to-use probes and reagents compatible with mainstream fully automated IHC/ISH platforms, improving throughput, repeatability, and turnaround time, driving growth in demand for related consumables and service-oriented testing.
Technology is evolving towards the integration of multiplex RNA-ISH and digital pathology: Achieving spatial resolution of multiple targets/combined IHC on the same slide, coupled with high-resolution imaging and algorithmic quantification, will promote companion diagnostics and remote consultations; simultaneously, influenced by stricter IVD compliance and quality control requirements, manufacturers will place greater emphasis on sensitivity, specificity, and batch-to-batch consistency.
LP Information, Inc. (LPI) ' newest research report, the “EBER Probe Industry Forecast” looks at past sales and reviews total world EBER Probe sales in 2025, providing a comprehensive analysis by region and market sector of projected EBER Probe sales for 2026 through 2032. With EBER Probe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EBER Probe industry.
This Insight Report provides a comprehensive analysis of the global EBER Probe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EBER Probe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global EBER Probe market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EBER Probe and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EBER Probe.
This report presents a comprehensive overview, market shares, and growth opportunities of EBER Probe market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
RNA Probe
DNA Probe
Segmentation by Probe Labeling:
DIG-labeled Probes
Biotin-labeled Probes
Direct Fluorescent-labeled Probes
Segmentation by Product Forms:
Ready-to-use
Concentrated
Segmentation by Application:
Hospital
Clinic
Research Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Leica Biosystems
Agilent
Roche Diagnostics GmbH
BioGenex
Biosystems Switzerland AG
ZytoVision GmbH
Ngaio Diagnostics
Biolynx
Dartmon
Celnovte Biotechnology
DIAGLOGIC BIOLABS
WuXi Diagnostics Lab (Shanghai)
Xiamen Talent Biomedical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global EBER Probe market?
What factors are driving EBER Probe market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EBER Probe market opportunities vary by end market size?
How does EBER Probe break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
EBER probes are nucleic acid probes used for in situ hybridization (ISH) to detect Epstein-Barr virus (EBV)-encoding small RNAs (EBER1/2). They are commonly used in FFPE tissue sections for nucleus staining/fluorescence localization, aiding in the determination of latent EBV infection and related tumor subtyping.
Upstream: Oligonucleotide/probe design and synthesis, labeling (DIG/biotin/fluorescence), enzymes and buffers, slides and mounting materials. Downstream: Hospital pathology departments and third-party testing, tumor/lymphoma and nasopharyngeal carcinoma diagnosis, transplant follow-up, and research institutions.
In 2025, the global unit price of EBER probes was $619, with sales of 169,000 units and a global annual production capacity of 180,000 units. The industry profit margin was 25-30%.
Global Market Trends:
Clinical demand for refined subtyping of EBV-related diseases is increasing. EBER-ISH, due to its ability to locate infected cells at the tissue level, will remain a key detection method; its penetration rate continues to increase in the management of lymphoma, nasopharyngeal carcinoma, and immunosuppression-related diseases.
Platforms are accelerating automation and standardization: More laboratories are adopting ready-to-use probes and reagents compatible with mainstream fully automated IHC/ISH platforms, improving throughput, repeatability, and turnaround time, driving growth in demand for related consumables and service-oriented testing.
Technology is evolving towards the integration of multiplex RNA-ISH and digital pathology: Achieving spatial resolution of multiple targets/combined IHC on the same slide, coupled with high-resolution imaging and algorithmic quantification, will promote companion diagnostics and remote consultations; simultaneously, influenced by stricter IVD compliance and quality control requirements, manufacturers will place greater emphasis on sensitivity, specificity, and batch-to-batch consistency.
LP Information, Inc. (LPI) ' newest research report, the “EBER Probe Industry Forecast” looks at past sales and reviews total world EBER Probe sales in 2025, providing a comprehensive analysis by region and market sector of projected EBER Probe sales for 2026 through 2032. With EBER Probe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EBER Probe industry.
This Insight Report provides a comprehensive analysis of the global EBER Probe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EBER Probe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global EBER Probe market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EBER Probe and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EBER Probe.
This report presents a comprehensive overview, market shares, and growth opportunities of EBER Probe market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
RNA Probe
DNA Probe
Segmentation by Probe Labeling:
DIG-labeled Probes
Biotin-labeled Probes
Direct Fluorescent-labeled Probes
Segmentation by Product Forms:
Ready-to-use
Concentrated
Segmentation by Application:
Hospital
Clinic
Research Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Leica Biosystems
Agilent
Roche Diagnostics GmbH
BioGenex
Biosystems Switzerland AG
ZytoVision GmbH
Ngaio Diagnostics
Biolynx
Dartmon
Celnovte Biotechnology
DIAGLOGIC BIOLABS
WuXi Diagnostics Lab (Shanghai)
Xiamen Talent Biomedical Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global EBER Probe market?
What factors are driving EBER Probe market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EBER Probe market opportunities vary by end market size?
How does EBER Probe break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
106 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for EBER Probe by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for EBER Probe by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
